SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Allegations that CEO Jensen Huang had a relationship with a woman suspected of ties to Chinese intelligence, and Nvidias board investigation into the matter, are driving concern about governance, possible information leaks and Huangs future as CEO. Traders disagree over whether the controversy threatens Nvidias leadership or is a distraction from its AI business, with some selling amid uncertainty and others viewing the decline as a buying opportunity.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims is drawing attention ahead of its Q3 report, with traders debating whether the sharp selloff signals weak results or reflects unexplained price pressure; claims of an earnings leak remain speculation. The Lilly obesity-drug agreement adds to the debate over growth potential versus pressure on margins.

XRP (XRP) is a cryptocurrency . XRP has a current supply of 99,985,583,260 with 63,516,606,953 in circulation. The last known price of XRP is 1.11892236 USD and is down -3.62 over the last 24 hours. It is currently trading on 1894 active market(s) with $1,884,610,999.15 traded over the last 24 hours. More information can be found at https://xrpl.org/.

Ripple

XRPs steep drop amid a broader crypto sell-off and reports of heavy liquidations has traders focused on whether the decline will continue or find support. The conversation is sharply divided between bearish calls for further losses and holders buying the dip, while some attribute weakness to broader market and regulatory uncertainty.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

Oppenheimers upgrade to Outperform, citing AMDs data-center and AI growth prospects, is fueling bullish attention, alongside discussion of Google Cloud using AMD EPYC processors in its AI infrastructure. Traders also speculate that Nvidia-related leadership headlines are driving a rotation into AMD, though others question whether the move is sustainable and warn the rally may be overextended.

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. The firm operates through the following geographical segments: United States and International. It offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

Trade Desk shares are surging ahead of Q3 earnings, with unusually heavy volume fueling speculation about short covering and unconfirmed earnings information. Traders are split between hoping for a results-driven turnaround and warning that weak advertising trends or guidance could reverse the rally.

iShares Trust - iShares Russell 2000 Index Fund

iShares Russell 2000 ETF

IWM is drawing attention after a sharp, near-vertical rally that traders describe as a low-volume squeeze despite reported ETF outflows and little apparent news. Some attribute the move to optimism about a possible Iran de-escalation and cooler inflation, while others question its sustainability and warn it may be an artificial or short-lived bounce.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics BRIUMVI growth drove a third-quarter revenue beat and higher full-year guidance, but the share-price pullback despite the results has fueled a sell the news debate. Traders are also focused on Phase 3 data for a subcutaneous BRIUMVI formulation as a future catalyst.

Churchill Capital Corp. XI is a blank check company. It was formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded by Michael Stuart Klein on June 4, 2025 and is headquartered in New York, NY.

Agility Robotics Inc.

Agility Robotics Inc. - Ordinary Shares - Class A

Agility Robotics is drawing attention after a sharp selloff following its de-SPAC debut, with traders blaming post-merger selling and raising concerns about dilution and the companys limited revenue and heavy losses. Others see long-term potential in humanoid robotics and point to commercial orders and strategic backers, leaving the discussion split between SPAC skepticism and confidence in the growth story.

Take-Two Interactive Software, Inc. engages in the development, publishing, and marketing of interactive software games. Its products are designed for console systems, handheld gaming systems, and personal computers, including smart phones and tablets, and are delivered through physical retail, digital download, online platforms, and cloud streaming services. The company was founded by Ryan A. Brant in 1993 and is headquartered in New York, NY.

Take-Two Interactive Software, Inc.

Take-Twos earnings report ahead of the scheduled GTA VI launch is driving attention, with traders focused on managements guidance and whether it will provide preorder details. Many expect the blockbuster game and its online monetization to boost the business, while others warn that high expectations may already be priced in and the stock could fall on cautious commentary or a sell-the-news reaction.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricors upcoming FDA decision on deramiocel for Duchenne muscular dystrophy is driving attention, with traders focused mainly on whether the agency will approve the upper-limb function indication by the Nov. 22 PDUFA date. Many expect approval, citing HOPE-3 data and a letter from trial investigators, while others stress the outcome remains uncertain given FDA concerns and the prior advisory committees negative vote on the cardiac evidence.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

HUN Q3 Earnings Miss Estimates, Sales Beat on Higher Prices

Huntsman's Q3 sales beat estimates on higher prices and volumes, while earnings missed expectations as segment profitability improved.

Huntsman Q3 2026 Earnings Call Transcript

Huntsman (NYSE:HUN) reported third-quarter financial results on Tuesday. The transcript from the company's third-quarter earnings call has been provided below.This transcript is brought to you by Benzinga APIs. Forread more...

Compared to Estimates, Huntsman (HUN) Q3 Earnings: A Look at Key Metrics

Although the revenue and EPS for Huntsman (HUN) give a sense of how its business performed in the quarter ended September 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Huntsman (HUN) Lags Q3 Earnings Estimates

Huntsman (HUN) delivered earnings and revenue surprises of -42.86% and +7.20%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?

Huntsman Announces Third Quarter 2026 Earnings

Huntsman Announces Third Quarter 2026 Earnings Huntsman Announces Third Quarter 2026 EarningsPR NewswireTHE WOODLANDS, Texas, Nov. 2, 2026 Third Quarter HighlightsThird quarter 2026 net loss attributable to Huntsman of $18 million compared to a net loss of $25 million in the prior year period...

Methanex (MEOH) Tops Q3 Earnings and Revenue Estimates

Methanex (MEOH) delivered earnings and revenue surprises of +16.40% and +7.84%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?

LIN Q3 Earnings Beat Estimates on Higher Americas Pricing & Volumes

Linde's Q3 earnings beat estimates as higher pricing, volume growth and strong electronics demand fueled sales gains, prompting a hike in its 2026 earnings outlook.

4 Chemical Stocks Set to Pull Off a Beat This Earnings Season

A recovery in end-market demand and self-help measures, including cost cuts and productivity gains, position AVNT, APD, DD, and HUN to beat Q3 earnings estimates.

Will Tronox (TROX) Report Negative Earnings Next Week? What You Should Know

Tronox (TROX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Linde Gears Up to Report Q3 Earnings: What's in Store for the Stock?

LIN gears up for Q3 earnings, with higher pricing, resilient end markets and project backlog supporting growth, while inflation and weak APAC demand pose risks.

• Reported GAAP EPS of $0.04 up 233.33% YoY
• Reported revenue of $1.72B up 17.60% YoY
• Huntsman expects 2026 capital expenditures to be approximately $160M; better results and cash flow are expected to reduce net debt leverage to approximately 4 times by year-end.

Huntsman reported a Q3 net loss and 108% effective tax rate; free cash flow was $82M versus $157M, net debt was $1.68B versus $1.58B, alongside disclosed market, cost and geopolitical risks.

Huntsmans adjusted EBITDA was $132M versus $94M; management cited higher volumes, stronger margins and cost savings, Advanced Materials volumes increased, and shareholders approved the merger.

Huntsman Corp. engages in the manufacturing of differentiated organic chemical products. It operates through the following segments: Polyurethanes, Performance Products, and Advanced Materials. The Polyurethanes segment manufactures and markets polyurethane chemicals, including MDI products, PO, polyols, PG, TPU, aniline, and MTBE. The Performance Products segment produces and sells amines, surfactants, LAB, and maleic anhydride to a variety of consumer and industrial end markets. The Advanced Materials segment provides basic liquid and solid epoxy resins, specialty resin compounds, cross linking, matting and curing agents, epoxy, acrylic, and polyurethane based polymer products. The company was founded by Jon Meade Huntsman Sr. in 1970 and is headquartered in The Woodlands, TX.

Huntsman Corp

Huntsman And Olin Merge In All-Stock Deal To Tackle Global Specialty Chemicals Challenges – ‘We Compete More Today Against Countries Than Companies’

Equity

Bearish Sentiment

<ul class="summary-bullets"><li>Huntsman shareholders will receive 0.5476 Olin shares for each Huntsman share.</li><li>Olin’s current chief executive, Ken Lane, will assume the top job at the new company, and Peter Huntsman will serve as non-executive chairman of the board.</li><li>The new 10-member board will have equal representation of five directors from each side, including the CEOs of both companies.</li></ul>Huntsman Corporation (HUN) and Olin Corporation (OLN) announced on Tuesday that they would merge in an all-stock transaction to create a giant in the North American specialty chemicals industry, with combined-company annual revenue exceeding $12 billion in 2025.At the time of writing, HUN stock was down more than 11% in premarket trading, while Olin was down about 1%.<h1 class="st-heading-1">The New Company: OlinHuntsman</h1>The combined entity, OlinHuntsman Corporation, would be headquartered in Texas and generate more than $400 million in cost savings, with a major portion realized within the first two years after the deal closes. It will also generate $125 million in cash tax benefits.The deal brings together the companies' complementary businesses, notably Huntsman’s portfolio of polyurethane systems, formulation technologies, and advanced materials, with Olin's chemical manufacturing and feedstock capabilities, including chlorine and caustic soda, among other things."As our industry continues to globalize, we compete more today against countries than companies, trade policies, and global supply chains than ever before," said Huntsman CEO Peter Huntsman. "This merger of equals takes two great companies and creates a much stronger global leader."<h1 class="st-heading-1">Terms Of The Deal</h1>As part of the combination, Huntsman shareholders will receive 0.5476 Olin shares for each Huntsman share. Olin shareholders will own the majority of the merged entity, with a 54.5% stake, while Huntsman shareholders will own the rest. According to calculations done by Reuters, the deal has an equity value of $2.43 billion, based on Olin’s last closing price on Monday.Olin’s current Chief Executive Officer, Ken Lane, will assume the top job at the new company, and Peter Huntsman will serve as non-executive chairman of the board. Huntsman Chief Financial Officer Phil Lister will become the new CFO of the combined company, and Olin CFO will become the Chief Integration Officer of OlinHuntsman.The new 10-member board will have equal representation of five directors from each side, including the CEOs of both companies.The deal is expected to close in the first half of next year.<h1 class="st-heading-1">What Do Retail Traders Think About OLN And HUN?</h1>On Stocktwits, retail sentiment toward OLN remained in ‘bearish’ territory, while it was ‘bullish’ on HUN over the last 24 hours.<a href="https://stocktwits.com/symbol/OLN">OLN stock</a> is up more than 21% so far this year, while <a href="https://stocktwits.com/symbol/HUN">HUN</a> has surged 59%, outperforming the S&amp;P 500.For updates and corrections, email newsroom[at]stocktwits[dot]com. &nbsp;

Close-up of two business people shaking hands while sitting at the working place. (Source: Getty Images) 

Huntsman Corporation (HUN) and Olin Corporation (OLN) announced on Tuesday that they would merge in an all-stock transaction to create a giant in the North American specialty chemicals industry, with combined-company annual revenue exceeding $12 billion i

The combined entity, OlinHuntsman Corporation, would generate more than $400 million in cost savings and $125 million in cash tax benefits.

Olin Corp.

Buying the dip

Selling or trimming

Holding

Waiting for the investigation results to decide

Nvidia ($NVDA) is down about 4% after its board opened an investigation into CEO Jensen Huang. What are you doing with the stock?

Stocktwits

) is down about 4% after its board opened an investigation into CEO Jensen Huang. What are you doing with the stock?

Current Price	$9.60
Prev Close	$9.45
Open	$9.48
Dividend Yield	8.38%
50-Day Moving Average	$9.00
Beta	1.11
Avg. Volume	3.05M
PE Ratio	-9.97

52-Week High	$16.09
52-Week Low	$8.00
Market Capitalization	$1.66B
EPS (Annual)	-$1.59
Price to Book	0.62
Revenue Per Employee	$947,166.67

Feed

News

Sentiment

Earnings

Fundamentals

Info

HUN Fundamentals